Meet GOLD's latest catalyst - ImmunoGen’s Dr Andreas Konieczny - European Medical Journal

Meet GOLD’s latest catalyst – ImmunoGen’s Dr Andreas Konieczny

EMJ GOLD
Bonus episode

Tune in and enjoy an exclusive preview of GOLD’s latest catalyst interview with Dr Andreas Konieczny, Vice President and Head of Medical Affairs Europe, ImmunoGen.

In this teaser of the full interview, Isabel and Jade digest Andreas’s thoughts on using medical affairs teams to drive drug launches, how to help different personalities work in harmony and how to gain leadership skills through the power of observation.

A little more on GOLD’s guest…

Dr Andreas Konieczny is Vice President and Head of Medical Affairs Europe at ImmunoGen, a biotech company specialising in the development of antibody-drug conjugates. He took up the role in September this year, having previously been Vice President and Medical Director, Oncology Europe, GSK. Andreas has been in the industry for more than 20 years, but trained and practised as a doctor before joining the business. Since then he’s worked for a number of major companies, following his passion for oncology every step of the way.

Rate this content's potential impact on patient outcomes

Average rating / 5. Vote count:

No votes so far! Be the first to rate this content.

Thank you!

Please share some more information on the rating you have given